Pfizer pulls sickle cell treatment Oxbryta off global markets
Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks
Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks
Prostate cancer presents a tricky screening challenge. Catching it early could mean dodging a painful journey with advanced cancer. Yet a sizable majority of prostate
Moderna was scolded by a U.K. trade group over a WhatsApp message that offered children a hefty $2,000 for participating in a clinical trial of
There are more than 7,000 rare and undiagnosed diseases globally.
The World Health Organization (WHO) today released guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels.
Having a high body roundness index (BRI) over a 6-year period was associated with an increased risk of developing cardiovascular disease for adults older than
Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent
The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading nonprofit organization focused on heart and brain health for all, is
In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the development of the CRISPR (Clustered Regularly
The University of Pittsburgh Schools of the Health Sciences has been awarded approximately $100 million from the U.S. Department of Defense (DOD) to continue a